Dreyer's Grand Ice Cream issued a voluntary recall after undeclared wheat was found in some of the bars, the FDA reported.
The U.S. Food and Drug Administration announced plans to reduce the amount of fluoride present in ingestible children’s products.
Pfizer and Novo Nordisk continue to fight for ownership of obesity startup Metsera; CDER Director George Tidmarsh leaves his ...
The Food and Drug Administration awarded the drug’s sponsor, biotech company Revolution Medicines, a new and unconventional ...
Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to ...
The latest of those is a bid valued at up to $10 billion for U.S. obesity-drug developer Metsera, up from a previous $9 billion offer it originally made, as it tries to usurp an already agreed-on deal ...
New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.
Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.
The firm's data and services revenues grew 26 percent to $81.3 million, while genomics revenues more than doubled to $252.9 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback